GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pharmedic Pharmaceutical Medicinal Joint Stock Company (HSTC:PMC) » Definitions » Probability of Financial Distress (%)

Pharmedic Pharmaceutical Medicinal Joint Stock Company (HSTC:PMC) Probability of Financial Distress (%)


View and export this data going back to 2009. Start your Free Trial

What is Pharmedic Pharmaceutical Medicinal Joint Stock Company Probability of Financial Distress (%)?

Pharmedic Pharmaceutical Medicinal Joint Stock Company does not have enough data to calculate Probability of Financial Distress (%).


Pharmedic Pharmaceutical Medicinal Joint Stock Company Probability of Financial Distress (%) Historical Data

The historical data trend for Pharmedic Pharmaceutical Medicinal Joint Stock Company's Probability of Financial Distress (%) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmedic Pharmaceutical Medicinal Joint Stock Company Probability of Financial Distress (%) Chart

Pharmedic Pharmaceutical Medicinal Joint Stock Company Annual Data
Trend
Probability of Financial Distress (%)

Pharmedic Pharmaceutical Medicinal Joint Stock Company Quarterly Data
Probability of Financial Distress (%)

Competitive Comparison of Pharmedic Pharmaceutical Medicinal Joint Stock Company's Probability of Financial Distress (%)

For the Drug Manufacturers - Specialty & Generic subindustry, Pharmedic Pharmaceutical Medicinal Joint Stock Company's Probability of Financial Distress (%), along with its competitors' market caps and Probability of Financial Distress (%) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pharmedic Pharmaceutical Medicinal Joint Stock Company's Probability of Financial Distress (%) Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Pharmedic Pharmaceutical Medicinal Joint Stock Company's Probability of Financial Distress (%) distribution charts can be found below:

* The bar in red indicates where Pharmedic Pharmaceutical Medicinal Joint Stock Company's Probability of Financial Distress (%) falls into.



Pharmedic Pharmaceutical Medicinal Joint Stock Company  (HSTC:PMC) Probability of Financial Distress (%) Explanation

Like the Altman Z-Score, the PFD measures a company's bankruptcy risk in the upcoming year. However, the main drawback of the Z-score is it does not apply to banks and insurance companies. According to Investopedia, the concept of "working capital" does not apply to banks and insurance companies, as financial institutions do not have typical current assets or current liabilities like inventories or accounts payable.


Pharmedic Pharmaceutical Medicinal Joint Stock Company Probability of Financial Distress (%) Related Terms

Thank you for viewing the detailed overview of Pharmedic Pharmaceutical Medicinal Joint Stock Company's Probability of Financial Distress (%) provided by GuruFocus.com. Please click on the following links to see related term pages.


Pharmedic Pharmaceutical Medicinal Joint Stock Company (HSTC:PMC) Business Description

Traded in Other Exchanges
N/A
Address
367 Nguyen Trai, Nguyen Cu Trinh Ward, District 1, TP. HCM, Ho Chi Minh, VNM
Pharmedic Pharmaceutical Medicinal Joint Stock Company is involved in the production and sales of pharmaceutical products, pharmaceuticals, cosmetics, medical supplies, and other products in the health sector.

Pharmedic Pharmaceutical Medicinal Joint Stock Company (HSTC:PMC) Headlines

From GuruFocus

PharMerica Corp. (PMC) CEO Gregory S Weishar buys 81,000 Shares

By GuruFocus Research GuruFocus Editor 08-13-2010

PharMerica Corp. Reports Operating Results (10-Q)

By gurufocus 10qk 08-05-2010

Weekly CFO Buys Highlight: PMC, ZBB

By gurujk gurujk 06-25-2012

PharMerica Corp. Reports Operating Results (10-Q)

By gurufocus 10qk 11-04-2010

PharMerica Corp. (PMC) CEO Gregory S Weishar buys 25,000 Shares

By GuruFocus Research GuruFocus Editor 11-16-2009